(Q51281953)
Statements
Immunotherapy of B-cell malignancies with genetically engineered human CD8+ natural killer T cells. (English)
1 reference
Pieper M
1 reference
Scheffold C
1 reference
Duwe S
1 reference
Rossig C
1 reference
Bisping G
1 reference
Stelljes M
1 reference
Tedder TF
1 reference
Jurgens H
1 reference
Berdel WE
1 reference
Kienast J
1 reference
1 April 2006
1 reference
20
1 reference
4
1 reference
729-732
1 reference
1 reference
1 reference
1 reference
1 reference